{"literatureAnnotation":{"id":827857761,"literature":{"id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"},"relatedObjects":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"},{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"}]},"publication":{"id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"},"related":{"GENE":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"DISEASE":[{"objCls":"Disease","id":"PA443937","name":"Drug Toxicity"},{"objCls":"Disease","id":"PA444773","name":"Leukopenia"},{"objCls":"Disease","id":"PA165817398","name":"Myelosuppression"}],"CHEMICAL":[{"objCls":"Chemical","id":"PA448515","name":"azathioprine"},{"objCls":"Chemical","id":"PA450379","name":"mercaptopurine"},{"objCls":"Chemical","id":"PA452634","name":"purine analogues"}]},"relationships":[{"id":1449187452,"literature":[{"id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Disease","id":"PA443937","name":"Drug Toxicity"}],"operator1":"and","operator2":"or","related":true,"terms":[]},{"id":1449187454,"literature":[{"id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Disease","id":"PA444773","name":"Leukopenia"}],"operator1":"and","operator2":"or","related":true,"terms":[]},{"id":1449187456,"literature":[{"id":10690840,"resourceId":"20136357","title":"Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?","sameAs":"https://www.ncbi.nlm.nih.gov/pubmed/20136357","type":"article"}],"object1s":[{"objCls":"Gene","id":"PA356","symbol":"TPMT","name":"thiopurine S-methyltransferase"}],"object2s":[{"objCls":"Disease","id":"PA165817398","name":"Myelosuppression"}],"operator1":"and","operator2":"or","related":true,"terms":[]}],"variantAnnotations":[{"characteristics":"thiopurine drugs, including azathioprine and 6-mercaptopurine","chemicals":[{"current":true,"resource":"PharmGKB","text":"azathioprine","url":"/chemical/PA448515"},{"current":true,"resource":"PharmGKB","text":"mercaptopurine","url":"/chemical/PA450379"},{"current":true,"resource":"PharmGKB","text":"purine analogues","url":"/chemical/PA452634"}],"genes":[{"current":true,"resource":"PharmGKB","text":"TPMT","url":"/gene/PA356"}],"id":1184174063,"literature":"20136357","literatureUrl":"/pmid/20136357","phenotypeCategories":["toxicity"],"race":"Mixed Population","significance":"not stated","variants":[{"current":true,"resource":"PharmGKB","text":"TPMT poor metabolizer phenotype","url":"/variant/PA166161834"}]},{"characteristics":"thiopurine drugs, including azathioprine and 6-mercaptopurine","chemicals":[{"current":true,"resource":"PharmGKB","text":"azathioprine","url":"/chemical/PA448515"},{"current":true,"resource":"PharmGKB","text":"mercaptopurine","url":"/chemical/PA450379"},{"current":true,"resource":"PharmGKB","text":"purine analogues","url":"/chemical/PA452634"}],"genes":[{"current":true,"resource":"PharmGKB","text":"TPMT","url":"/gene/PA356"}],"id":1184174068,"literature":"20136357","literatureUrl":"/pmid/20136357","phenotypeCategories":["efficacy","toxicity"],"race":"Mixed Population","significance":"not stated","variants":[{"current":true,"resource":"PharmGKB","text":"TPMT intermediate metabolizer phenotype","url":"/variant/PA166157952"}]}]}